Redpoint Investment Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$709K Sell
3,248
-790
-20% -$180K 0.1% 250
2022
Q2
$846K Hold
4,038
0.1% 249
2022
Q1
$979K Hold
4,038
0.1% 251
2021
Q4
$1.05M Sell
4,038
-71
-2% -$18.4K 0.08% 275
2021
Q3
$1.08M Hold
4,109
0.09% 256
2021
Q2
$1.01M Hold
4,109
0.08% 288
2021
Q1
$797K Buy
4,109
+459
+13% +$92K 0.07% 326
2020
Q4
$776K Buy
3,650
+98
+3% +$19.5K 0.08% 281
2020
Q3
$609K Sell
3,552
-5,875
-62% -$1.08M 0.07% 304
2020
Q2
$1.81M Sell
9,427
-982
-9% -$161K 0.1% 235
2020
Q1
$1.53M Buy
10,409
+34
+0.3% +$5.42K 0.1% 242
2019
Q4
$1.61M Sell
10,375
-361
-3% -$52K 0.08% 307
2019
Q3
$1.45M Buy
10,736
+5,739
+115% +$752K 0.08% 314
2019
Q2
$610K Hold
4,997
0.03% 427
2019
Q1
$520K Buy
4,997
+998
+25% +$103K 0.03% 437
2018
Q4
$455K Buy
3,999
+1,399
+54% +$150K 0.03% 442
2018
Q3
$300K Hold
2,600
0.02% 507
2018
Q2
$269K Hold
2,600
0.01% 476
2018
Q1
$256K Hold
2,600
0.01% 476
2017
Q4
$220K Buy
+2,600
New +$215K 0.01% 506

Other funds holding RMD

Redpoint Investment Management's RMD Position: Q3 2022 in Review

Redpoint Investment Management reduced its ResMed (RMD) stake by 20% in Q3 2022, selling an estimated $180K and leaving 3,248 shares worth $709K. The position accounts for 0.1% of the portfolio, ranked #250.

Redpoint Investment Management first reported a position in RMD in Q4 2017 and has held it in 20 quarters since. The position peaked at $1.81M in Q2 2020. 667 funds tracked by Wall St. Rank hold RMD as of Q3 2022.

  • Redpoint Investment Management held 3,248 shares of ResMed worth $709K as of Q3 2022.
  • Redpoint Investment Management sold 790 ResMed shares in Q3 2022, an estimated $180K.
  • ResMed made up 0.1% of Redpoint Investment Management's portfolio in Q3 2022, its #250 holding.
  • Redpoint Investment Management first reported a position in ResMed in Q4 2017 and has held it in 20 quarters since.
  • Redpoint Investment Management's ResMed position peaked at $1.81M in Q2 2020.
  • 667 funds tracked by Wall St. Rank held ResMed as of Q3 2022.

Based on Redpoint Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.